Current management of herpes zoster: the European view.

@article{Volpi2005CurrentMO,
  title={Current management of herpes zoster: the European view.},
  author={Antonio Volpi and Gerd Gross and Jana Hercogov{\'a} and Robert Wood Johnson},
  journal={American journal of clinical dermatology},
  year={2005},
  volume={6 5},
  pages={317-25}
}
The overall incidence of herpes zoster in Europe is approximately 3 per 1000 people per year and more than 10 per 1000 people per year in those aged >80 years. Post herpetic neuralgia (PHN) is a common debilitating complication of herpes zoster, particularly in patients aged >50 years, in persons with severe pain or rash at presentation, and in those with significant prodromal symptoms. Antiviral drugs can effectively control acute symptoms and, if used early enough in the course of the illness… CONTINUE READING